The board of directors of China Health Group Limited announced that Ms. Meng Junfeng has been appointed as an independent non-executive Director and members of the audit committee, remuneration committee and nomination committee of the Company with effect from 21 April 2020. From October 2011 to March 2018, she was the Executive Director and Head of Shenzhen investment department in Citic M&A Fund Management Co., Limited responsible for investment business, including deal sourcing and execution etc. She is the Managing Director of GSUM Fund Management Co., Limited since April 2018 responsible for investment business including fund raising, deal sourcing, execution, real estate finance business operation in South China and providing financial advisory service for clients. There is no service contract between Ms. Meng and the Company. Ms. Meng has not been appointed for any fixed term but will be subject to retirement by rotation and re-election at the annual general meeting of the Company in accordance with the Bye-laws of the Company. Following the resignation of Mr. Xiao Zuhe as an independent non-executive Director on 22 January 2020, Mr. Xiao ceased to be chairman of the audit committee of the Company. Mr. Lai Liangquan, the independent non-executive Director, has been appointed as chairman of audit committee of the Company with effect from 21 April 2020.